An Italian Observation of Antiretroviral Treatment in Participants Taking Darunavir/ Cobicistat Plus Emtricitabine and Tenofovir Alafenamide Fumarate

Condition:   Human Immunodeficiency Virus (HIV) Intervention:   Drug: D/C/F/TAF Fixed-Dose Combination (FDC) Sponsor:   Janssen-Cilag S.p.A. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials